Cvs Pharmacy #02896 Durable Medical Equipment & Medical Supplies Location: 675 Washington St, Middletown, Connecticut 06457 Phone: (860) 344-1320 |
Cvs Pharmacy #00364 Durable Medical Equipment & Medical Supplies Location: 308 Main Street Ext, Middletown, Connecticut 06457 Phone: (860) 344-1857 |
Rotech Durable Medical Equipment & Medical Supplies Location: 19 Tuttle Pl, Middletown, Connecticut 06457 Phone: (860) 688-1118 |
Stop & Shop Pharmacy #623 Durable Medical Equipment & Medical Supplies Location: 416 East Main Street, Middletown, Connecticut 06457 Phone: (860) 346-1779 |
Price Chopper Inc. Pharmacy Location: 855 Washington Street, Middletown, Connecticut 06457 Phone: (860) 740-7707 |
Walgreens #2858 Durable Medical Equipment & Medical Supplies Location: 633 Washington St, Middletown, Connecticut 06457 Phone: (860) 346-7628 |
Walgreens #12338 Durable Medical Equipment & Medical Supplies Location: 311 E Main St, Middletown, Connecticut 06457 Phone: (860) 704-0135 |
Hancock Pharmacy V Llc Durable Medical Equipment & Medical Supplies Location: 644 Main St, Middletown, Connecticut 06457 Phone: (860) 346-9700 |
Connecticut Brace And Limb, Llc Medicare Supplier Location: 131 Main Street Ext, Middletown, Connecticut 06457 Phone: (860) 740-2154 |
Middlesex Eye Physicians Optical De Eyewear Supplier (Equipment, not the service) Location: 400 Saybrook Rd, Middletown, Connecticut 06457 Phone: (860) 347-8300 |
Lenscrafters #1017 Eyewear Supplier (Equipment, not the service) Location: 460 Main St, Middletown, Connecticut 06457 Phone: (860) 347-4664 |
News Archive
A powerful new way of analyzing how drugs interact with molecules in the body could aid the design of better treatments with fewer side-effects.
A hospital pneumonia survival rate of 93 percent may sound good, but knowing that it's actually merely "fair" can help people pick a better hospital, according to new research. A "good" survival rate would be from 95 percent to 98 percent, medical experts say.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has filed a clinical trial application (CTA) with the European Medicines and Healthcare products Regulatory Agency (MHRA) seeking clearance to initiate its Phase 1/2 clinical trial using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD).
NMMI publishes original research papers, reviews, case reports, editorials and letters to the editor on nuclear medicine and a wide range of related sciences. These include radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. June-Key Chung, MD, PhD, from the Seoul National University College of Medicine will serve as editor-in-chief. He will be supported by an international editorial board.
› Verified 3 days ago